DSCSA: Preparing for the Full Serialization of the U.S. Pharmaceutical Supply Chain

The U.S. Drug Supply Chain Security Act (DSCSA) will fundamentally change how pharmaceutical companies do business in the United States. Though the U.S. Food and Drug Administration on August 25, 2023, announced an extended stabilization period that will be in effect until November 27, 2024, giving the industry more time to comply, the key takeaway is, Don’t stop preparing.

This paper gets into the specifics of the DSCSA and what all actors in the U.S. pharmaceutical supply chain must do to comply. If you’re a manufacturer, wholesale distributor, dispenser (i.e., pharmacy or healthcare system), repackager, or third-party logistics provider (3PL), download it today and contact us to discuss your needs for DSCSA compliance.